GLP-1 Market
LLY $1152.70 ▲ +0.0% NVO $43.24 ▲ +0.1% PFE $27.61 ▼ -0.1% VKTX $28.99 ▼ -1.3% KLRA $12.83 ▼ -0.7% GPCR $35.00 ▼ -0.3% RHHBY $54.04 ▼ -1.1%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Rosuvastatin Calcium

Company
Daiichi Sankyo
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
35 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

35 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 19, 2026

Find a Clinical Trial Near Me

See recruiting studies for Rosuvastatin Calcium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03016819

    Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

    Not yet reported Advenchen Laboratories, LLC 325 participants Est. completion 2028-12 24 sites
    Obstructive sleep apnea Other conditions: Alveolar Soft Part Sarcoma, Synovial Sarcoma, Soft-Tissue Sarcoma
    View official trial listing →
  • Recruiting NCT NCT04319627

    Statins for Venous Event Reduction in Patients With Venous Thromboembolism

    Not yet reported Ottawa Hospital Research Institute 2700 participants Est. completion 2028-04 31 sites Stand-alone
    Other conditions: Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04602754

    Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

    Not yet reported EMS 228 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT04699279

    Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)

    Not yet reported Nanjing Medical University 300 participants Est. completion 2024-12-31 5 sites Stand-alone
    Other conditions: Acute Aortic Syndrome, Aortopathy
    View official trial listing →
  • Recruiting NCT NCT04847752

    Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

    Tongji Hospital 1000 participants Est. completion 2028-12-31 1 site
    Cardiovascular disease Other conditions: Large-Artery Atherosclerosis (Embolus/Thrombosis)
    View official trial listing →
  • Recruiting NCT NCT04968509

    Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis

    Not yet reported Beijing Anzhen Hospital 160 participants Est. completion 2028-01 1 site Stand-alone
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Recruiting NCT NCT05155137

    Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

    Not yet reported Hospital Moinhos de Vento 8518 participants Est. completion 2030-12-14 2 sites Stand-alone
    Cardiovascular disease Other conditions: Cognitive Decline
    View official trial listing →
  • Recruiting NCT NCT05483010

    Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

    Not yet reported Washington University School of Medicine 16 participants Est. completion 2028-05-31 1 site Stand-alone
    Other conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT05614739

    FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

    Not yet reported Eli Lilly and Company 677 participants Est. completion 2027-06 82 sites Stand-alone
    Other conditions: Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05832229

    Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256 participants Est. completion 2029-08-31 13 sites Stand-alone
    Other conditions: Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis Due to Hepatitis C
    View official trial listing →
  • Recruiting NCT NCT05845424

    High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

    Not yet reported Samsung Medical Center 6000 participants Est. completion 2030-06-30 1 site Stand-alone
    Metabolic syndrome Other conditions: Coronary Artery Calcification, Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT06102863

    Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

    Not yet reported Peking University People's Hospital 38 participants Est. completion 2025-09-01 1 site Stand-alone
    Other conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
    View official trial listing →
  • Recruiting NCT NCT06358313

    Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

    Not yet reported Kafrelsheikh University 600 participants Est. completion 2026-05-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06501443

    LATAM LOWERS LDL-C

    Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Recruiting NCT NCT06603363

    Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

    Not yet reported Prof. Maurovich-Horvat Pál 140 participants Est. completion 2028-12-15 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerotic Plaque, Coronary Computed Tomography Angiography, Statin Therapy, Multidetector Computed Tomography, Heart Diseases, Arteriosclerosis, Vascular Diseases, Hyperlipidemia
    View official trial listing →
  • Recruiting NCT NCT06604117

    Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

    Xuanwu Hospital, Beijing 200 participants Est. completion 2027-10 1 site
    Cardiovascular disease Other conditions: Atherosclerosis of Artery, Lipid Disorder, Statin
    View official trial listing →
  • Recruiting NCT NCT06686615

    A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2000 participants Est. completion 2028-01-31 163 sites
    Other conditions: Primary Hypercholesterolemiia, Mixed Dyslipidemia
    View official trial listing →
  • Recruiting NCT NCT06765265

    Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

    Not yet reported King Edward Medical University 152 participants Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Recruiting NCT NCT06767345

    Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

    Not yet reported Korea University Anam Hospital 408 participants Est. completion 2028-06-25 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis of Coronary Artery, Plaque, Atherosclerotic
    View official trial listing →
  • Recruiting NCT NCT06767774

    Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

    Not yet reported Korea University Anam Hospital 2000 participants Est. completion 2030-01-31 1 site
    Cardiovascular disease Other conditions: Diabetes, Statin
    View official trial listing →
  • Recruiting NCT NCT06772168

    Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

    Not yet reported CMG Pharmaceutical Co. Ltd 240 participants Est. completion 2027-02-01 24 sites Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemia
    View official trial listing →
  • Recruiting NCT NCT06785740

    Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 300 participants Est. completion 2029-09 4 sites
    Cardiovascular disease Other conditions: TIA
    View official trial listing →
  • Recruiting NCT NCT06896708

    Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome

    Not yet reported Liu yong 766 participants Est. completion 2028-03-01 7 sites Stand-alone
    Other conditions: Chronic Coronary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT07032389

    A Polypill for Acute Coronary Syndrome

    Not yet reported University of Texas Southwestern Medical Center 1000 participants Est. completion 2030-07-31 2 sites Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Recruiting NCT NCT07083206

    A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

    Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 site
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT07128888

    Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection

    Not yet reported Gan & Lee Pharmaceuticals. 60 participants Est. completion 2026-07-05 1 site Stand-alone
    Other conditions: Obesity or Overweight
    View official trial listing →
  • Recruiting NCT NCT07232069

    PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

    Not yet reported Duke University 1500 participants Est. completion 2031-07 23 sites Stand-alone
    Cardiovascular disease Other conditions: Prevention & Control, Premature Atherosclerosis
    View official trial listing →
  • Recruiting NCT NCT07300280

    A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

    Not yet reported Merck Sharp & Dohme LLC 60 participants Est. completion 2026-10-21 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT07303816

    Statins to Prevent Cancer Associated Blood Clots

    Not yet reported Brigham and Women's Hospital 4000 participants Est. completion 2032-03-31 9 sites Stand-alone
    Other conditions: Venous Thromboembolism, Cancer, Cardiovascular Events
    View official trial listing →
  • Recruiting NCT NCT07344610

    Effects of Short-term Intensive Statin Therapy on Lipid Levels

    General Hospital of Shenyang Military Region 800 participants Est. completion 2026-12-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07460960

    TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

    Not yet reported Lomonosov Moscow State University Medical Research and Educational Center 150 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen Profile, Testosterone
    View official trial listing →
  • Recruiting NCT NCT07619131

    A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

    Not yet reported AstraZeneca 600 participants Est. completion 2027-07-30 152 sites Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Recruiting NCT NCT07629999

    Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants

    Not yet reported Bristol-Myers Squibb 136 participants Est. completion 2027-06-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07704918

    Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00090298

    Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

    Not yet reported Organon and Co 2815 participants Est. completion 2004-12
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00114491

    Rosuvastatin Affecting Aortic Valve Endothelium

    Hospital Pedro Hispano 200 participants Est. completion 2005-05 1 site
    Other conditions: Atherosclerosis, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00127218

    High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly

    Not yet reported Johns Hopkins University 145 participants Est. completion 2008-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00132717

    A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)

    Not yet reported Organon and Co 450 participants Est. completion 2007-06-01
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00160745

    Rosuvastatin and Renal Endothelial Function

    Not yet reported University of Erlangen-Nürnberg Medical School 46 participants Est. completion 2006-09 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00176332

    Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure

    Not yet reported University of Leipzig 40 participants Est. completion 2006-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00184951

    Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

    Not yet reported Radboud University Medical Center 30 participants Est. completion 2005-07 5 sites
    Other conditions: HIV Infections, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00214604

    Type III Dysbetalipoproteinemia

    Not yet reported AstraZeneca 30 participants Est. completion 2007-02 2 sites
    Other conditions: Hyperlipoproteinemia Type III
    View official trial listing →
  • Completed NCT NCT00214630

    LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

    Not yet reported AstraZeneca 825 participants Est. completion 2007-08 56 sites
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT00235950

    Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

    Not yet reported AstraZeneca 255 participants Est. completion 2006-03 18 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00240266

    Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

    Not yet reported AstraZeneca 15 participants Est. completion 2004-12 1 site
    Metabolic syndrome Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00240305

    A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

    Not yet reported AstraZeneca 15 participants Est. completion 2006-05 1 site
    Metabolic syndrome Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00240331

    AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

    Not yet reported AstraZeneca 2776 participants Est. completion 2008-10 239 sites Stand-alone
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT00240344

    Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

    AstraZeneca 2650 participants Est. completion 2008-02 75 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT00240357

    Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia

    Not yet reported AstraZeneca 1175 participants 109 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00241488

    DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

    Not yet reported AstraZeneca 1362 participants Est. completion 2007-02 34 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00249912

    Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

    Not yet reported Takeda 415 participants Est. completion 2007-04 92 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00251680

    Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

    Not yet reported Takeda 400 participants Est. completion 2007-05 77 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00262548

    C-Reactive Protein (CRP) in Obese Diabetic Women

    Not yet reported AstraZeneca 100 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00296387

    Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

    Not yet reported AstraZeneca 1160 participants Est. completion 2007-10 102 sites
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00300482

    Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

    Not yet reported Abbott 1445 participants 1 site
    Other conditions: Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00309374

    Anti-Inflammatory Effect of Statins in the Human Endotoxin Model

    Not yet reported Medical University of Vienna 6 participants Est. completion 2006-07 1 site
    Other conditions: Endotoxemia
    View official trial listing →
  • Completed NCT NCT00315510

    Rosuvastatin and Ischemia Reperfusion

    Not yet reported Radboud University Medical Center 20 participants Est. completion 2007-08 1 site
    Other conditions: Ischemia
    View official trial listing →
  • Completed NCT NCT00329160

    Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

    Not yet reported AstraZeneca 214 participants Est. completion 2008-10 27 sites
    Other conditions: Hypercholesteremia
    View official trial listing →
  • Completed NCT NCT00329173

    PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

    Not yet reported AstraZeneca 1000 participants Est. completion 2004-08
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00335699

    Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome

    Not yet reported AstraZeneca 370 participants Est. completion 2007-01 7 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00344123

    Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

    Not yet reported Johns Hopkins University 29 participants Est. completion 2008-05 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00347217

    Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

    AstraZeneca 3840 participants Est. completion 2009-01 215 sites
    Other conditions: Hypercholesteremia
    View official trial listing →
  • Completed NCT NCT00364559

    Effect of Rosuvastatin in Intracerebral Hemorrhage

    Not yet reported Universidad Autonoma de San Luis Potosí 75 participants Est. completion 2006-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Completed NCT NCT00379249

    Rosuvastatin ORBITAL Germany

    Not yet reported AstraZeneca 8000 participants Est. completion 2004-02
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00388596

    A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.

    Not yet reported GlaxoSmithKline 36 participants 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Withdrawn NCT NCT00396240

    ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

    Not yet reported AstraZeneca 1294 participants
    Other conditions: Primary Hypercholesterolaemia
    View official trial listing →
  • Terminated NCT NCT00427960

    Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

    Not yet reported AstraZeneca 55 participants Est. completion 2008-02 9 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00446940

    Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

    Not yet reported Bader, Ted, M.D. 16 participants Est. completion 2007-03 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00462748

    A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

    Not yet reported Organon and Co 786 participants Est. completion 2008-06
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00463606

    A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

    Not yet reported AstraZeneca 760 participants Est. completion 2008-02 168 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00464503

    Statins and the Urinary Proteome

    Not yet reported Universiteit Antwerpen 7 participants Est. completion 2007-10 1 site
    Other conditions: Statin Induced Proteinuria
    View official trial listing →
  • Completed NCT NCT00468923

    Heart Outcomes Prevention Evaluation-3

    Not yet reported Population Health Research Institute 12705 participants Est. completion 2016-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00487318

    Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin

    Not yet reported Bader, Ted, M.D. 40 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00505154

    Effect of Rosuvastatin on Left Ventricular Remodeling

    Not yet reported Oslo University Hospital 75 participants Est. completion 2013-07 1 site
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT00525824

    12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe

    Not yet reported AstraZeneca 1743 participants Est. completion 2008-09 9 sites
    Other conditions: Hypercholesterolemia, Coronary Heart Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00526708

    Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )

    AstraZeneca 5000 participants Est. completion 2007-11 3 sites
    Other conditions: Dyslipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT00549653

    A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men

    Not yet reported GlaxoSmithKline 44 participants Est. completion 2007-12 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00554138

    The Effect of Rosuvastatin on Adenosine Metabolism

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2008-04 1 site Stand-alone
    Other conditions: Adenosine Metabolism
    View official trial listing →
  • Completed NCT NCT00574782

    Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)

    AstraZeneca 2660 participants
    Other conditions: Hypercholesterolemia, Coronary Heart Disease, Peripheral Vascular Disease, CVA, Diabetes
    View official trial listing →
  • Completed NCT NCT00585143

    Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

    Not yet reported AstraZeneca 37 participants Est. completion 2008-10 6 sites Stand-alone
    Other conditions: Dyslipidemia, Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00631189

    Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients

    Not yet reported AstraZeneca 668 participants Est. completion 2008-10 170 sites
    Other conditions: Type IIa and IIb Hypercholesterolaemia
    View official trial listing →
  • Terminated NCT NCT00651378

    Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

    Not yet reported Organon and Co 87 participants Est. completion 2005-06-01 Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00653445

    Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg

    Not yet reported AstraZeneca Est. completion 2005-06 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Heart Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00653744

    Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

    Not yet reported AstraZeneca 1700 participants Est. completion 2004-03 Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00653965

    Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

    Not yet reported AstraZeneca 3000 participants Est. completion 2005-02 Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00654303

    OLE Study to Evaluate Safety / Efficacy of ZD4522

    Not yet reported AstraZeneca 3500 participants Est. completion 2005-02 Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00654485

    COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

    Not yet reported AstraZeneca 940 participants Est. completion 2005-02 Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00654537

    STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

    Not yet reported AstraZeneca 5625 participants Est. completion 2004-10 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00654602

    48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

    Not yet reported AstraZeneca 1500 participants Est. completion 2004-11
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00657527

    Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

    Not yet reported AstraZeneca 280 participants Est. completion 2002-12 Stand-alone
    Cardiovascular disease Other conditions: Myocardial Ischaemia
    View official trial listing →
  • Completed NCT NCT00673660

    Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 375 participants Est. completion 2009-10 5 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00679510

    Rosuvastatin in Rheumatoid Arthritis (RORA)

    Not yet reported, Not yet reported University of Dundee 50 participants Est. completion 2008-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00680082

    Observational Usage Study of Statins in Primary Care in France

    AstraZeneca 2100 participants Est. completion 2009-07 25 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00681395

    Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

    Not yet reported AstraZeneca 64 participants 1 site
    Other conditions: Adverse Events, Pharmacokinetic
    View official trial listing →
  • Completed NCT NCT00683618

    Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

    Not yet reported AstraZeneca 934 participants Est. completion 2009-07 6 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00688454

    C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

    AstraZeneca 3392 participants Est. completion 2008-01
    Other conditions: Hypercholesteremia
    View official trial listing →
  • Completed NCT NCT00689416

    Effects of Crestor on Inflammation of Atherosclerotic Plaques

    Not yet reported AstraZeneca 74 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Atherosclerosis, Inflammatory Activity in Carotid Arteries
    View official trial listing →
  • Completed NCT NCT00693589

    Effect of Homocysteine-lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease

    Not yet reported Insel Gruppe AG, University Hospital Bern 36 participants Est. completion 2007-04
    Cardiovascular disease Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00695539

    Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients

    AstraZeneca 810 participants Est. completion 2008-12 6 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00718796

    Naturopathic Treatment for the Prevention of Cardiovascular Disease

    Not yet reported The Canadian College of Naturopathic Medicine 300 participants Est. completion 2009-10 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00719693

    Assessment of the Effect of Food on ABT-143 Bioavailability

    Not yet reported AstraZeneca 115 participants 1 site Stand-alone
    Other conditions: Pharmacokinetic Variables
    View official trial listing →
  • Completed NCT NCT00728780

    Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

    Not yet reported AstraZeneca 32 participants 1 site
    Other conditions: Adverse Events, Pharmacokinetic Variables
    View official trial listing →
  • Completed NCT NCT00730132

    Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)

    Organon and Co 712 participants Est. completion 2009-08
    Other conditions: Coronary Heart Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00766025

    Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin

    Not yet reported AstraZeneca 50 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: CYP2C19 Poor, Extensive Metabolizers
    View official trial listing →
  • Status unknown NCT NCT00767130

    DNA Diagnostic System for Statin Safety and Efficacy

    Genomas, Inc 750 participants Est. completion 2009-12 3 sites
    Other conditions: Hypercholesterolemia, Myopathy
    View official trial listing →
  • Completed NCT NCT00781560

    Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal

    AstraZeneca 2575 participants Est. completion 2009-07 15 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00783042

    Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

    Not yet reported AstraZeneca 80 participants Est. completion 2009-05 1 site
    Other conditions: Atherosclerosis, Inflammatory Activity in Coronary Arteries
    View official trial listing →
  • Completed NCT NCT00783263

    A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

    Not yet reported Organon and Co 440 participants Est. completion 2010-05 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00812955

    Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

    Not yet reported AstraZeneca 474 participants Est. completion 2009-06 129 sites Stand-alone
    Other conditions: Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00826358

    Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

    Not yet reported AstraZeneca 90 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00862251

    Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)

    Not yet reported Organon and Co 808 participants Est. completion 2011-03
    Other conditions: Cardiovascular Disorder, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00874757

    Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects

    University of Nebraska 20 participants Est. completion 2011-09-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00885872

    Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)

    Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Hyperlipidemia, Atherosclerosis
    View official trial listing →
  • Withdrawn NCT NCT00913562

    Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma

    Not yet reported Medical University of Vienna Est. completion 2014-11 1 site
    Other conditions: Glaucoma, Diabetes
    View official trial listing →
  • Available NCT NCT00934258

    Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia

    National Taiwan University Hospital
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00964106

    Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

    Not yet reported GlaxoSmithKline 87 participants Est. completion 2011-08-29 2 sites Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Available NCT NCT00965315

    A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome

    National Taiwan University Hospital
    Other conditions: Diabetes, CVD
    View official trial listing →
  • Completed NCT NCT00966472

    Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

    Not yet reported Ottawa Hospital Research Institute 24 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Squamous Cell Carcinoma, Non-Small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT00970606

    STIP: Statin Trial for Influenza Patients

    Not yet reported Gordon Bernard 7 participants Est. completion 2011-07 21 sites Stand-alone
    Other conditions: Acute Respiratory Distress Syndrome, Influenza, H1N1 Influenza
    View official trial listing →
  • Completed NCT NCT00978419

    Pilot Trial of Statin Use in Burn Patients

    Not yet reported Vanderbilt University Medical Center 40 participants Est. completion 2011-05 1 site
    Other conditions: Burns
    View official trial listing →
  • Terminated NCT NCT00979121

    Statins for Acutely Injured Lungs From Sepsis

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 745 participants Est. completion 2013-11 40 sites
    Other conditions: Sepsis, Acute Lung Injury
    View official trial listing →
  • Completed NCT NCT00984932

    Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension

    Not yet reported University of Alexandria 40 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00987974

    Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury

    Not yet reported Radboud University Medical Center 48 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Ischemia Reperfusion Injury, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00990028

    Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury

    Not yet reported, Not yet reported Universidad Autonoma de San Luis Potosí 40 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Head Injury
    View official trial listing →
  • Status unknown NCT NCT01010516

    Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

    Not yet reported University of Ioannina 120 participants 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01011127

    Different Metabolic Effects of Statins

    Gachon University Gil Medical Center Est. completion 2010-08 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01021488

    Rosuvastatin for Preventing Deep Vein Thrombosis

    Not yet reported Hallym University Medical Center 180 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Deep Vein Thrombosis, Venous, Thrombosis, Prevention
    View official trial listing →
  • Withdrawn NCT NCT01023503

    Observational Study To Evaluate Statins Patterns Of Use In Spain

    AstraZeneca Est. completion 2012-07 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01047501

    Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

    Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01138072

    A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

    Not yet reported GlaxoSmithKline 14 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT01146483

    Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuvastatin

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 16 participants Est. completion 2011-12 1 site
    Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Completed NCT NCT01153334

    Efficacy of Early Intensive ROsuvastatin Therapy in Patients With ST-segment Elevation Myocardial Infarction Undergoing PrimARY Percutaneous Coronary Intervention (the ROSEMARY Trial)

    Not yet reported Yonsei University 125 participants Est. completion 2013-06-27 1 site Stand-alone
    Other conditions: ST-segment Elevation AMI
    View official trial listing →
  • Completed NCT NCT01154036

    MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

    Not yet reported Organon and Co 1547 participants Est. completion 2012-10 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01164397

    Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

    AstraZeneca 268 participants Est. completion 2010-12 9 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Withdrawn NCT NCT01164540

    Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

    Not yet reported AstraZeneca 3000 participants Est. completion 2013-03 Stand-alone
    Other conditions: Venous Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT01170585

    A Trial of Rosuvastatin in Systemic Lupus Erythematosus

    Not yet reported Imperial College London 33 participants Est. completion 2014-06 2 sites
    Other conditions: Atherosclerosis, Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01178853

    Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 48 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01183585

    A Study of RO4917838 With Rosuvastatin in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 18 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01218347

    Influence of Organic Anion Transporting Polypeptide1B1(OATP1B1) Genotype on Rosuvastatin PK, PD and Lipid Profiles

    Not yet reported Seoul National University Hospital 34 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Organic Anion Transporting Polypeptide1B1 (OATP1B1), Rosuvastatin
    View official trial listing →
  • Completed NCT NCT01218802

    Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks

    Not yet reported University Hospitals Cleveland Medical Center 147 participants Est. completion 2014-05 1 site
    Other conditions: HIV Infections, Heart Disease
    View official trial listing →
  • Completed NCT NCT01223625

    Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function

    Not yet reported Odense University Hospital 87 participants Est. completion 2010-06 1 site
    Other conditions: Endothelial Dysfunction, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01241903

    Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

    Not yet reported Susan Smyth 54 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Blood Platelets
    View official trial listing →
  • Completed NCT NCT01245894

    Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment

    Not yet reported Odense University Hospital 87 participants Est. completion 2010-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01259791

    Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Statin Myopathy
    View official trial listing →
  • Completed NCT NCT01288742

    TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin

    Not yet reported Tibotec Pharmaceuticals, Ireland 33 participants Est. completion 2011-05 Stand-alone
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Status unknown NCT NCT01325818

    The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris

    Not yet reported Yokohama City University Medical Center 150 participants Est. completion 2016-02 1 site
    Other conditions: Coronary Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01350141

    A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

    Not yet reported Pfizer 46 participants Est. completion 2012-06 35 sites
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01352897

    Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

    AstraZeneca 800 participants Est. completion 2010-12 1 site
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Status unknown NCT NCT01382277

    Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume

    Not yet reported Peking University First Hospital 600 participants Est. completion 2013-04 2 sites Stand-alone
    Cardiovascular disease Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01389388

    Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease

    Not yet reported Diakonhjemmet Hospital 114 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Carotid Artery Plaque, Ankylosing Spondylitis, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01414803

    Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia

    Not yet reported Yonsei University 180 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01415466

    Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 36 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01455935

    Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention

    Not yet reported Jacobs Neurological Institute 90 participants Est. completion 2014-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01469416

    Drug Interaction Study of Clopidogrel and Rosuvastatin

    Not yet reported University of California, San Francisco 10 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01489943

    A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2011-11-10 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01490398

    Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve

    Not yet reported Asan Medical Center 56 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Hypertension, Cardiovascular Risk Factors
    View official trial listing →
  • Completed NCT NCT01493856

    A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

    Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01524601

    The Rosuvastatin In TrAnsplant Recipients Study

    Not yet reported University of Oslo School of Pharmacy 20 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01526317

    A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

    Not yet reported Yuhan Corporation 36 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
    View official trial listing →
  • Completed NCT NCT01544309

    LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts

    Not yet reported Listen Trial Group 1049 participants 133 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01547377

    Zinc and Selenium Supplementation in Atherosclerosis

    Not yet reported Universidade Federal do Rio Grande do Norte 76 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Dietary Selenium Deficiency, Dietary Zinc Deficiency
    View official trial listing →
  • Completed NCT NCT01548157

    Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

    Not yet reported Hanmi Pharmaceutical Company Limited 28 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01567774

    Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-06 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01567826

    Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy

    Not yet reported Annapoorna Kini 87 participants Est. completion 2012-02 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01573143

    Statin Therapy In Cardiac Surgery

    Not yet reported University of Oxford 1922 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Myocardium; Injury
    View official trial listing →
  • Completed NCT NCT01582165

    Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance

    Not yet reported Oslo University Hospital 66 participants Est. completion 2016-06 1 site
    Other conditions: Angina Pectoris
    View official trial listing →
  • Completed NCT NCT01613794

    Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis

    Not yet reported Leiden University Medical Center 255 participants Est. completion 2016-12 3 sites Stand-alone
    Other conditions: Deep Vein Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT01622777

    The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study

    Not yet reported Alejandra Guillermina Miranda Diaz 34 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Diabetic Polyneuropathy
    View official trial listing →
  • Completed NCT NCT01623115

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

    Not yet reported Sanofi 486 participants Est. completion 2014-12 91 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01623921

    Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma

    Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2013-08 1 site
    Other conditions: Blunt Chest Trauma, Acute Respiratory Distress Syndrome
    View official trial listing →
  • Status unknown NCT NCT01624857

    Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft

    Not yet reported China National Center for Cardiovascular Diseases 400 participants Est. completion 2014-06 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT01634906

    Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy

    Not yet reported Sint Franciscus Gasthuis 55 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Hyperlipidemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01644175

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)

    Not yet reported Sanofi 316 participants Est. completion 2014-04 76 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01644188

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)

    Not yet reported Sanofi 720 participants Est. completion 2015-07 126 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01646307

    Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI

    Not yet reported Beijing Anzhen Hospital 1000 participants Est. completion 2013-06 1 site
    Other conditions: Focus of Study
    View official trial listing →
  • Status unknown NCT NCT01653119

    Peking and Rotterdam on Mission to Reduce Coronary Artery Disease

    Not yet reported Peking University Third Hospital 1000 participants Est. completion 2015-12 1 site
    Other conditions: Acute Coronary Syndrome, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01660191

    A Study Comparing CoQ10 Levels While Taking 3 Different Statins

    Not yet reported University of Kansas Medical Center 134 participants Est. completion 2013-10 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01663402

    ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

    Not yet reported Sanofi 18924 participants Est. completion 2018-01-23 1388 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01697735

    The Therapeutic Effects of Statins and Berberine on the Hyperlipemia

    Not yet reported Wenzhou Medical University 24 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01725230

    Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib

    Not yet reported AstraZeneca 42 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01730040

    Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

    Not yet reported Regeneron Pharmaceuticals 355 participants Est. completion 2014-05 97 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01730053

    Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

    Not yet reported Regeneron Pharmaceuticals 305 participants Est. completion 2014-05-31 93 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01751074

    To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers

    Not yet reported GlaxoSmithKline 18 participants Est. completion 2013-03-14 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01764295

    Clinical Study for Patients With Hypertension Associated With Dyslipidemia

    Not yet reported Daewoong Pharmaceutical Co. LTD. 150 participants Est. completion 2013-07 1 site
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01775579

    Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium

    Not yet reported Hanmi Pharmaceutical Company Limited 36 participants Est. completion 2013-06 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01798602

    Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial

    Not yet reported Canadian Critical Care Trials Group 8 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: H1N1 Influenza
    View official trial listing →
  • Completed NCT NCT01813357

    Does Rosuvastatin Delay Progression of Atherosclerosis in HIV

    Not yet reported Bayside Health 84 participants Est. completion 2018-11-01 2 sites Stand-alone
    Cardiovascular disease Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT01823900

    Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

    Not yet reported Severance Hospital 58 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01863225

    Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

    Not yet reported Resverlogix Corp 13 participants Est. completion 2013-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT01874743

    Rosuvastatin to Decrease Residual Immune Activation in HIV Infection

    Not yet reported Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 40 participants Est. completion 2013-09 2 sites Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Status unknown NCT NCT01899027

    Rosuvastatin for Preventing Complications in Renal Ablation

    Not yet reported University of Roma La Sapienza 112 participants Est. completion 2017-12 1 site
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01921946

    To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

    Not yet reported Boryung Pharmaceutical Co., Ltd 50 participants Est. completion 2013-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01923077

    Intensive Statin Therapy in Patients With AMI

    Not yet reported Svendborg Hospital 140 participants Est. completion 2013-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01926782

    Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)

    Not yet reported Regeneron Pharmaceuticals 803 participants Est. completion 2015-04 83 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01929070

    A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

    Not yet reported Hanmi Pharmaceutical Company Limited 12 participants Est. completion 2013-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01929512

    Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

    Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01953835

    A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184

    Not yet reported GlaxoSmithKline 37 participants Est. completion 2014-03-10 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01954394

    Open Label Study of Long Term Safety Evaluation of Alirocumab

    Not yet reported Sanofi 986 participants Est. completion 2017-06-30 177 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01959399

    Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin

    Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Healthy Subjects, Pharmacokinetics of ASP015K
    View official trial listing →
  • Completed NCT NCT01964365

    Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 30 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01968577

    Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention

    Not yet reported Kleber Bomfim Araujo Martins 528 participants Est. completion 2013-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01970215

    TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)

    Not yet reported Xention Ltd 364 participants Est. completion 2014-07 17 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01971606

    Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study

    Not yet reported Yonsei University 234 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.
    View official trial listing →
  • Terminated NCT NCT01972178

    Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

    Not yet reported Pronova BioPharma 113 participants Est. completion 2014-08 29 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT01975194

    Rosuvastatin in African Americans With Cerebrovascular Disease

    Not yet reported Wayne State University 20 participants Est. completion 2013-08 1 site Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Status unknown NCT NCT01982461

    A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

    Not yet reported Pin Siang Medical Biotechnology Co., Ltd. 40 participants 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT02008786

    Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD

    Not yet reported Cardiology Research UBC 18 participants Est. completion 2019-09-13 1 site Stand-alone
    Other conditions: Coronary Artery Dissection, Spontaneous
    View official trial listing →
  • Completed NCT NCT02029625

    Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

    Not yet reported NVP Healthcare 41 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT02030054

    Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)

    Not yet reported University of Roma La Sapienza 150 participants Est. completion 2015-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02041117

    Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging

    Not yet reported Beijing Tiantan Hospital 162 participants Est. completion 2018-11-06 1 site
    Other conditions: Intracranial Arterial Stenosis
    View official trial listing →
  • Completed NCT NCT02047175

    CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

    Not yet reported Chong Kun Dang Pharmaceutical 64 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02075619

    Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2014-07-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02082665

    Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam

    Not yet reported GlaxoSmithKline 6 participants Est. completion 2016-08-01 4 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02083627

    A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

    Not yet reported Astellas Pharma Europe B.V. 25 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Drug-Drug Interaction (DDI), Intestinal Absorption, Healthy Subjects, Pharmacokinetics of Rosuvastatin, Pharmacokinetics of Fidaxomicin
    View official trial listing →
  • Status unknown NCT NCT02087540

    Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

    Not yet reported IlDong Pharmaceutical Co Ltd 310 participants 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02089061

    Drug Interaction Statin

    Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2014-05 Stand-alone
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT02089399

    Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 32 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02106845

    Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

    Not yet reported Bayer 42 participants Est. completion 2018-06-12 5 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02107898

    Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)

    Not yet reported Sanofi 216 participants Est. completion 2015-09 32 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT02114697

    Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging

    Not yet reported Emory University 9 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02127320

    Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

    Not yet reported Hanmi Pharmaceutical Company Limited 24 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02215174

    Rosuvastatin Interethnic PK Study

    Not yet reported University of California, San Francisco 21 participants Est. completion 2018-12-06 2 sites Stand-alone
    Other conditions: Statin Pharmacokinetics Pre and Post Gastric Bypass Surgery
    View official trial listing →
  • Completed NCT NCT02231931

    Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin

    Not yet reported Boehringer Ingelheim 24 participants Est. completion 2015-01-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02232360

    Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone

    Not yet reported Gachon University Gil Medical Center 106 participants Est. completion 2020-12 6 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02233218

    The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

    Not yet reported Yuhan Corporation 60 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Healthy Male Volunteer
    View official trial listing →
  • Completed NCT NCT02234492

    The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

    Not yet reported Ottawa Heart Institute Research Corporation 35 participants Est. completion 2018-10 2 sites
    Cardiovascular disease Other conditions: Human Immunodeficiency Virus (HIV)
    View official trial listing →
  • Completed NCT NCT02262143

    Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

    Not yet reported IlDong Pharmaceutical Co Ltd 362 participants Est. completion 2017-06 1 site Stand-alone
    Other conditions: Mixed Dyslipidemias
    View official trial listing →
  • Completed NCT NCT02283515

    Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 65 participants Est. completion 2014-06
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Status unknown NCT NCT02284503

    Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)

    Not yet reported Shanghai Zhongshan Hospital 1350 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Non-ST-elevation Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT02289430

    to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

    Not yet reported NVP Healthcare 59 participants Est. completion 2015-02 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02289963

    Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

    Not yet reported Sanofi 199 participants Est. completion 2016-04 27 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02299245

    Rosuvastatin Effect on Telomere-telomerase System in ACS

    Not yet reported Xiao-dong Zhuang 400 participants Est. completion 2016-11 Stand-alone
    Other conditions: Telomere Shortening, Telomere Length, Mean Leukocyte, 22q Telomere Deletion Syndrome
    View official trial listing →
  • Completed NCT NCT02300363

    DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

    Not yet reported Lexicon Pharmaceuticals 24 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02305355

    Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 site Stand-alone
    Type 2 diabetes Other conditions: Hypertriglycemia
    View official trial listing →
  • Status unknown NCT NCT02305862

    A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques

    Not yet reported Capital Medical University 150 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Arteriosclerosis, Diabetes Mellitus, Lipid Disorder
    View official trial listing →
  • Completed NCT NCT02317016

    Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer

    Not yet reported AstraZeneca 44 participants Est. completion 2018-05-22 13 sites Stand-alone
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02364258

    Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients

    Not yet reported Children's Mercy Hospital Kansas City 28 participants Est. completion 2017-12-27 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02369250

    Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects

    Not yet reported Government Dental College and Research Institute, Bangalore 110 participants Est. completion 2014-09 Stand-alone
    Other conditions: Furcation Defects
    View official trial listing →
  • Completed NCT NCT02378064

    Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation

    Not yet reported CHEOL WHAN LEE, M.D., Ph.D 50 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin System
    View official trial listing →
  • Completed NCT NCT02390375

    Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia

    Not yet reported Daewon Pharmaceutical Co., Ltd. 348 participants Est. completion 2016-05 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02401256

    CYP2B6 Genetics and Drug Interactions in Healthy Volunteers

    Not yet reported Indiana University 70 participants Est. completion 2016-05-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02411903

    The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

    Not yet reported The Third Affiliated Hospital of Guangzhou Medical University 160 participants Est. completion 2016-08 Stand-alone
    Other conditions: Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder)
    View official trial listing →
  • Status unknown NCT NCT02418884

    The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus

    Not yet reported Sir Run Run Shaw Hospital 122 participants Est. completion 2018-03
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02428374

    Role of Immune Responses After Acute Myocardial Infarction

    Not yet reported Federal University of São Paulo 300 participants Est. completion 2019-07 1 site
    Other conditions: Myocardial Fibrosis
    View official trial listing →
  • Completed NCT NCT02434497

    A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

    Not yet reported AstraZeneca 9 participants Est. completion 2016-11-17 6 sites Stand-alone
    Other conditions: Homozygous Familial Hypercholesterolemia (HoFH)
    View official trial listing →
  • Completed NCT NCT02445352

    Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia

    Not yet reported Alvogen Korea 379 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02449187

    Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 16 participants Est. completion 2018-03-09 1 site
    Other conditions: Diabetes, Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT02458755

    Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis

    Not yet reported Samsung Medical Center 80 participants Est. completion 2018-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Intracranial Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02476006

    Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

    Not yet reported Sanofi 998 participants Est. completion 2019-04-12 153 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02518503

    High Potency Statins and the Risk of Diabetes

    Canadian Network for Observational Drug Effect Studies, CNODES 136966 participants Est. completion 2013-02
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02532309

    A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques

    Not yet reported Wei Liu 308 participants 1 site Stand-alone
    Other conditions: Carotid Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02546648

    PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study

    Not yet reported McMaster University 100 participants Est. completion 2016-08 2 sites Stand-alone
    Other conditions: Atherosclerotic Disease, Perioperative Bleeding
    View official trial listing →
  • Completed NCT NCT02549846

    AdminiStration of Statin On Acute Ischemic stRoke patienT Trial

    Not yet reported Hyogo Medical University 270 participants Est. completion 2017-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02551172

    Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD

    Not yet reported Hanmi Pharmaceutical Company Limited 270 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Withdrawn NCT NCT02561845

    Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

    AstraZeneca Est. completion 2015-10
    Other conditions: PCI Patients
    View official trial listing →
  • Status unknown NCT NCT02561884

    A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2015-10
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02569645

    Rosuvastatin in the Treatment of Rectal Cancer

    Not yet reported AHS Cancer Control Alberta 45 participants Est. completion 2021-09-24 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT02574845

    DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)

    Not yet reported Boehringer Ingelheim 18 participants Est. completion 2015-12-14 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02579499

    Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

    Not yet reported Yonsei University 4400 participants Est. completion 2022-11 1 site Stand-alone
    Other conditions: Coronary Artery Diseasse
    View official trial listing →
  • Completed NCT NCT02586129

    Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

    Not yet reported Yuhan Corporation 249 participants Est. completion 2017-07-07 1 site
    Other conditions: Dyslipidemia, Type II Diabetes
    View official trial listing →
  • Completed NCT NCT02586155

    Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

    Not yet reported Resverlogix Corp 2425 participants Est. completion 2021-06-21 214 sites Stand-alone
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT02592317

    A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

    Not yet reported Aragon Pharmaceuticals, Inc. 23 participants Est. completion 2027-12-31 3 sites Stand-alone
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Completed NCT NCT02594800

    Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 50 participants Est. completion 2019-06-30 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02600520

    Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 45 participants Est. completion 2015-05
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Terminated NCT NCT02608242

    PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

    Not yet reported Yuhan Corporation 123 participants Est. completion 2016-06 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02611518

    A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 32 participants Est. completion 2016-06-14 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02612714

    Statin Lowering Testosterone and Sexual Function

    Not yet reported Chang Gung Memorial Hospital 151 participants Est. completion 2014-12 1 site
    Other conditions: Sexual Dysfunction
    View official trial listing →
  • Completed NCT NCT02626234

    A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors

    Not yet reported Novartis Pharmaceuticals 32 participants Est. completion 2017-04-28 15 sites Stand-alone
    Other conditions: cMET-dysregulated Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT02645227

    Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2015-10 1 site
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Withdrawn NCT NCT02662894

    Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

    Not yet reported EMS Est. completion 2020-12 Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02671097

    Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

    Not yet reported Bayer 30 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Healthy Volunteers, Pharmacokinetics, Drug Interaction
    View official trial listing →
  • Completed NCT NCT02675309

    A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

    Not yet reported Tanabe Pharma Corporation 28 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02685462

    Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin

    Not yet reported Tobira Therapeutics, Inc. 36 participants Est. completion 2016-02-23 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02707224

    Clinical Trial to Compare the Pharmacokinetics of DP-R208

    Not yet reported Alvogen Korea 40 participants Est. completion 2015-06 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02709187

    DP-R208 Pharmacokinetic Study

    Not yet reported Alvogen Korea 37 participants Est. completion 2016-05 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02730689

    A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

    Not yet reported Alvogen Korea 66 participants Est. completion 2015-01 Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02737319

    A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).

    Not yet reported University of Sao Paulo 493 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT02741245

    A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

    Not yet reported Organon and Co 321 participants Est. completion 2017-01-18 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02748057

    A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)

    Not yet reported Organon and Co 135 participants Est. completion 2017-12-11 Stand-alone
    Other conditions: Hypercholesterolemia, Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02749994

    A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

    Not yet reported IlDong Pharmaceutical Co Ltd 396 participants Est. completion 2017-02 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02767310

    Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

    Not yet reported Verisfield UK Ltd. Greek Branch 49 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02785874

    Statin With Palliative Therapy for HCC

    Not yet reported Taipei Medical University WanFang Hospital 4 participants Est. completion 2016-11-01 1 site
    Other conditions: HCC
    View official trial listing →
  • Status unknown NCT NCT02789475

    DP-R212 Pharmacokinetic Study

    Not yet reported Alvogen Korea 38 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT02814500

    DP-R212 Pharmacokinetic Study Phase I

    Not yet reported Alvogen Korea 36 participants Est. completion 2016-09 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02850081

    Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

    Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-alone
    Cardiovascular disease Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Completed NCT NCT02854527

    Transporter Cocktail Mutual Interaction

    Not yet reported Boehringer Ingelheim 30 participants Est. completion 2016-11-19 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02859480

    Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI

    Not yet reported Korea University Anam Hospital 300 participants Est. completion 2019-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Coronary Disease
    View official trial listing →
  • Terminated NCT NCT02901067

    STAT-STatin and Aspirin in Trauma

    Not yet reported Denver Health and Hospital Authority 43 participants Est. completion 2021-08-01 1 site Stand-alone
    Other conditions: Wounds and Injuries, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT02913794

    Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

    Boryung Pharmaceutical Co., Ltd 541 participants Est. completion 2018-03-29 1 site
    Cardiovascular disease Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT02951962

    A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

    Not yet reported Yuhan Corporation 60 participants Est. completion 2016-09 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02962310

    Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

    Not yet reported Torrent Pharmaceuticals Limited 48 participants Est. completion 2009-11 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02962323

    Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 48 participants Est. completion 2009-12 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02963116

    A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

    Not yet reported AstraZeneca 12 participants Est. completion 2017-03-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02968160

    A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

    Not yet reported Yuhan Corporation 55 participants Est. completion 2018-02 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02977065

    To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

    Not yet reported Chong Kun Dang Pharmaceutical 62 participants Est. completion 2018-01-30 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT02979704

    A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia

    Not yet reported, Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90 participants Est. completion 2017-07 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02982798

    The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 40 participants Est. completion 2018-01-31 1 site Stand-alone
    Other conditions: Diabetes, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02985099

    1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 80 participants Est. completion 2016-07 1 site
    Type 2 diabetes Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02995720

    A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

    Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-05-30 Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT03007524

    Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin

    Not yet reported Nanjing First Hospital, Nanjing Medical University 80 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT03010475

    A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects

    Not yet reported Novo Nordisk A/S 41 participants Est. completion 2017-08-09 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT03011775

    Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

    Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome
    View official trial listing →
  • Completed NCT NCT03019549

    A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

    Not yet reported AstraZeneca 42 participants Est. completion 2017-05-22 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03043196

    1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 60 participants Est. completion 2016-04 1 site
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT03044873

    Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin

    Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2017-03-27 1 site Stand-alone
    Other conditions: Autoimmune Diseases, Inflammatory Diseases
    View official trial listing →
  • Completed NCT NCT03074630

    Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)

    Not yet reported Amsterdam UMC, location VUmc 12 participants Est. completion 2018-04 1 site Stand-alone
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03088254

    Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

    Not yet reported Jeil Pharmaceutical Co., Ltd. 126 participants Est. completion 2017-12-04 12 sites Stand-alone
    Other conditions: Dyslipidemia With Hypertension
    View official trial listing →
  • Terminated NCT NCT03113994

    Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

    Not yet reported Dr. B. Catharine. Craven 8 participants Est. completion 2022-12-31 2 sites
    Metabolic syndrome Other conditions: Spinal Cord Injuries, Osteoporosis
    View official trial listing →
  • Active, not recruiting NCT NCT03169985

    Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque

    Not yet reported Samsung Medical Center 280 participants Est. completion 2027-01-28 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03187496

    Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.

    Not yet reported Enanta Pharmaceuticals, Inc 24 participants Est. completion 2017-06-14 1 site Stand-alone
    MASH
    View official trial listing →
  • Completed NCT NCT03204058

    Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2017-02-23
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT03210532

    Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

    Not yet reported Daewon Pharmaceutical Co., Ltd. 129 participants Est. completion 2017-09 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT03216304

    Safinamide Steady State Interaction With Rosuvastatin

    Not yet reported Cross Research S.A. 24 participants Est. completion 2017-07-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03217409

    A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

    Not yet reported Yuhan Corporation 85 participants Est. completion 2019-05-23 4 sites Stand-alone
    Other conditions: Diabetes Mellitus and Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03245229

    A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

    Not yet reported Idorsia Pharmaceuticals Ltd. 20 participants Est. completion 2017-09-18 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03288038

    The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

    Not yet reported Shin Poong Pharmaceutical Co. Ltd. 382 participants Est. completion 2015-11-19 20 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03329729

    PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT

    Elpen Pharmaceutical Co. Inc. 4700 participants Est. completion 2019-01-30 1 site
    Other conditions: Dyslipidemias, Hyperlipidemias, Risk Factor, Cardiovascular, Quality of Life
    View official trial listing →
  • Completed NCT NCT03359291

    Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects

    Not yet reported Actelion 20 participants Est. completion 2017-12-04 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT03417388

    Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

    Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03418974

    Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

    Not yet reported Fudan University 10000 participants Est. completion 2021-12-31 2 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03446261

    Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

    Not yet reported Yuhan Corporation 140 participants Est. completion 2019-03-05 2 sites Stand-alone
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03474562

    High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

    Not yet reported Yuhan Corporation 100 participants Est. completion 2019-06-07 4 sites Stand-alone
    Cardiovascular diseasePrediabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03494270

    High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

    Not yet reported Yuhan Corporation 270 participants Est. completion 2019-09-26 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03521700

    Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

    Not yet reported, Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 150 participants Est. completion 2015-12-30 1 site Stand-alone
    Other conditions: Renal Artery Obstruction, Stents, Lipids, Glomerular Filtration Rate, Blood Pressure
    View official trial listing →
  • Withdrawn NCT NCT03526367

    A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI

    Not yet reported Shenyang Northern Hospital Est. completion 2019-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Contrast-induced Acute Kidney Injury, Primary PCI, Rosuvastatin, Hydration
    View official trial listing →
  • Completed NCT NCT03536598

    Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

    Not yet reported HK inno.N Corporation 203 participants Est. completion 2017-09-04 Stand-alone
    Other conditions: Hypertension With Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03540355

    Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

    Not yet reported EMS 406 participants Est. completion 2025-01-23 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03561298

    A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects

    Not yet reported BeiGene 18 participants Est. completion 2018-07-02 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03566316

    Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

    Not yet reported IlDong Pharmaceutical Co Ltd 134 participants Est. completion 2017-06-16 1 site Stand-alone
    Other conditions: Hypertension With Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03597412

    Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

    Not yet reported Yuhan Corporation 236 participants Est. completion 2020-08-12 1 site Stand-alone
    Cardiovascular diseaseType 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03610321

    Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia

    Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 70 participants Est. completion 2021-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03639493

    Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

    Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-05-17 1 site Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Status unknown NCT NCT03657758

    Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]

    Not yet reported Kobe University 75 participants Est. completion 2021-08-31 1 site
    Cardiovascular disease Other conditions: Angina Pectoris
    View official trial listing →
  • Completed NCT NCT03690778

    The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

    Not yet reported Jeil Pharmaceutical Co., Ltd. 42 participants Est. completion 2019-02-01 1 site Stand-alone
    Other conditions: Diabetes, Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT03699774

    Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers

    Not yet reported Daiichi Sankyo 24 participants Est. completion 2015-07-06 1 site Stand-alone
    Other conditions: Drug Pharmacokinetics in Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03707899

    The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 49 participants Est. completion 2019-05-22 1 site Stand-alone
    Other conditions: Hypertension With Dyslipidemia
    View official trial listing →
  • Completed NCT NCT03715101

    A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly

    Not yet reported Seoul National University Hospital 20 participants Est. completion 2016-04 Stand-alone
    Other conditions: Elderly
    View official trial listing →
  • Status unknown NCT NCT03719820

    Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )

    Wei-Hai Xu 550 participants Est. completion 2021-06-30 38 sites
    Cardiovascular disease Other conditions: Intracranial Atherosclerosis ICAS
    View official trial listing →
  • Status unknown NCT NCT03742544

    Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy

    IlDong Pharmaceutical Co Ltd 600 participants Est. completion 2020-10-30
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03753477

    Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

    Not yet reported Daewoong Pharmaceutical Co. LTD. 64 participants Est. completion 2018-02-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03757390

    Bioequivalence Study of CJ-30060 in Healthy Volunteers

    Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-12-14 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03806101

    Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

    Not yet reported Pfizer 12 participants Est. completion 2019-04-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03847506

    Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

    Not yet reported HK inno.N Corporation 127 participants Est. completion 2020-12-02 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03864042

    Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

    Not yet reported Pfizer 56 participants Est. completion 2023-05-29 29 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Metastatic Melanoma
    View official trial listing →
  • Status unknown NCT NCT03867942

    BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.

    Not yet reported LG Chem 48 participants Est. completion 2019-08-31 Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT03889314

    The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial

    Not yet reported Minneapolis Heart Institute Foundation 25 participants Est. completion 2022-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Cardiovascular Risk Factor, Adverse Effect
    View official trial listing →
  • Completed NCT NCT03907423

    Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

    Not yet reported Rehab Werida 70 participants Est. completion 2021-01-31 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03949374

    Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

    Not yet reported Yonsei University 126 participants Est. completion 2018-06-01 1 site
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03951207

    Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

    Not yet reported Yuhan Corporation 259 participants Est. completion 2021-09-29 1 site Stand-alone
    Other conditions: Dyslipidemias, Hypertension
    View official trial listing →
  • Completed NCT NCT03954366

    Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

    Not yet reported pharmaand GmbH 36 participants Est. completion 2021-06-09 7 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT03970798

    A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin

    Not yet reported Kyowa Kirin Co., Ltd. 50 participants Est. completion 2019-07-31 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03988101

    Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

    Not yet reported Yonsei University 100 participants Est. completion 2025-05-30 1 site Stand-alone
    Other conditions: Venous Thromboembolism, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04074551

    A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

    Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04092595

    A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

    Not yet reported Pfizer 12 participants Est. completion 2020-01-15 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04094519

    A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

    Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2020-12-27 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04098003

    Investigation of the Gut Microbiome and Statin Response

    Not yet reported Sony Tuteja 45 participants Est. completion 2026-03-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04124003

    A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin

    Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2020-01-03 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT04161001

    Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

    Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT04174456

    Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy

    Not yet reported Dong-A University 40 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT04231435

    Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Metformin

    Not yet reported Celgene 24 participants Est. completion 2020-02-21 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04252300

    Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants

    Not yet reported Bayer 14 participants Est. completion 2020-12-07 1 site Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT04253353

    A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

    Not yet reported Pfizer 12 participants Est. completion 2020-08-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04268394

    A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677

    Not yet reported Celgene 48 participants Est. completion 2021-06-02 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT04303806

    Effect of Rosuvastatin on the Clinical Features of Preeclampsia

    Not yet reported Assiut University 80 participants Est. completion 2023-12 Stand-alone
    Other conditions: Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT04398771

    To Evaluate Safety and Effectiveness of RovatitanTab.

    LG Chem 1000 participants Est. completion 2022-05-31
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT04433533

    Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia

    Not yet reported Yonsei University 200 participants Est. completion 2023-12 1 site
    Other conditions: Left Ventricular Diastolic Dysfunction, Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT04455581

    A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 8 participants Est. completion 2021-08-31 Stand-alone
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04491643

    Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

    Not yet reported Fudan University 48 participants Est. completion 2025-04-11 1 site Stand-alone
    Other conditions: Endometrial Carcinoma Stage I
    View official trial listing →
  • Completed NCT NCT04491682

    Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

    Not yet reported, Not yet reported Fudan University 36 participants Est. completion 2022-06-20 1 site Stand-alone
    Other conditions: Atypical Endometrial Hyperplasia
    View official trial listing →
  • Completed NCT NCT04498741

    Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

    Not yet reported Enanta Pharmaceuticals, Inc 89 participants Est. completion 2021-06-01 1 site Stand-alone
    Other conditions: RSV Infection
    View official trial listing →
  • Status unknown NCT NCT04504851

    Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct

    Not yet reported National University Hospital, Singapore 154 participants Est. completion 2021-03-31 6 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT04542382

    Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)

    Not yet reported University of California, San Francisco 11 participants Est. completion 2023-08-11 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT04581759

    Endovascular Treatment and RIPC in Acute Ischemic Stroke

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-10-30 1 site
    Cardiovascular disease Other conditions: Endovascular Treatment
    View official trial listing →
  • Completed NCT NCT04590937

    A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2021-01-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04621227

    Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity

    Not yet reported Pfizer 16 participants Est. completion 2021-05-13 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04621669

    Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 36 participants Est. completion 2021-09-08 1 site Stand-alone
    Other conditions: Drug-drug Interaction,SHR3680
    View official trial listing →
  • Completed NCT NCT04626973

    Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

    Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04659070

    To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

    Not yet reported Hanlim Pharm. Co., Ltd. 156 participants Est. completion 2022-05-19 1 site Stand-alone
    Other conditions: Primary Hypercholesterolemia, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04737408

    Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

    Not yet reported Bjarne Linde Noergaard 120 participants Est. completion 2023-08 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT04764851

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

    Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 site
    Other conditions: Drug-Interactions
    View official trial listing →
  • Completed NCT NCT04776889

    The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

    Not yet reported National Cancer Institute, Egypt 70 participants Est. completion 2020-12-30 1 site Stand-alone
    Other conditions: Prostate Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT04824911

    Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease

    Not yet reported Chang Gung Memorial Hospital 376 participants Est. completion 2025-02-28 1 site Stand-alone
    Cardiovascular disease Other conditions: Dual Antiplatelet Therapy, Statin
    View official trial listing →
  • Completed NCT NCT04826354

    Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

    Not yet reported Korea University Anam Hospital 582 participants Est. completion 2023-06-28 2 sites Stand-alone
    Other conditions: Atheroscleroses, Coronary
    View official trial listing →
  • Completed NCT NCT04862962

    Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia

    Laboratorios Silanes S.A. de C.V. 120 participants Est. completion 2022-02-15 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04887194

    PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates

    Not yet reported Mirati Therapeutics Inc. 40 participants Est. completion 2022-12-22 5 sites Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT04895059

    Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

    Not yet reported Laboratorios Silanes S.A. de C.V. 36 participants Est. completion 2018-01-22 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04895098

    Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD

    Akrikhin 1000 participants Est. completion 2022-07-08 31 sites
    Cardiovascular disease Other conditions: Lipid Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT04923152

    Effective Dose of Statin Post PCI

    Not yet reported Shiraz University of Medical Sciences 582 participants Est. completion 2021-04-01 1 site Stand-alone
    Other conditions: Statin Dose
    View official trial listing →
  • Completed NCT NCT04931147

    A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

    Not yet reported Redx Pharma Ltd 90 participants Est. completion 2023-03-08 1 site Stand-alone
    Other conditions: Fibrosis, Inflammation, Idiopathic Pulmonary Fibrosis, Non-alcoholic Steatohepatitis, Liver Diseases, Kidney Diseases
    View official trial listing →
  • Status unknown NCT NCT04974814

    Effect of Statin Preloading in STEMI in Improving PCI Outcomes

    Not yet reported Beni-Suef University 99 participants Est. completion 2023-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05002244

    A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

    Not yet reported Celltrion 37 participants Est. completion 2021-09-13 1 site Stand-alone
    Other conditions: Health, Subjective
    View official trial listing →
  • Completed NCT NCT05045638

    Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants

    Not yet reported Amgen 13 participants Est. completion 2021-10-10 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05064488

    Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 40 participants Est. completion 2021-12-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05072054

    Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 80 participants Est. completion 2022-08-31 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05154123

    Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)

    Not yet reported Atea Pharmaceuticals, Inc. 29 participants Est. completion 2021-12-23 1 site Stand-alone
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Completed NCT NCT05184179

    Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab

    Daewoong Pharmaceutical Co. LTD. 5450 participants Est. completion 2022-08-16 1 site
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05197517

    Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition

    Not yet reported Rania Mahmoud Mohamed 38 participants Est. completion 2020-10-01 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05236530

    Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir

    Not yet reported Novartis Pharmaceuticals 48 participants Est. completion 2022-10-17 1 site Stand-alone
    Other conditions: Malaria
    View official trial listing →
  • Status unknown NCT NCT05298475

    Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2024-04-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT05334108

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

    Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT05368545

    Influence of Lipid Lowering on Impaired Coronary Flow

    Not yet reported Aarhus University Hospital 109 participants Est. completion 2024-04-17 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05368805

    Fruquintinib DDI Study With P-gp and BCRP Substrates

    Not yet reported Hutchmed 32 participants Est. completion 2022-04-22 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT05384262

    A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

    Not yet reported AstraZeneca 183 participants Est. completion 2024-06-14 3 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05514938

    Polypill in Acute Coronary Syndrome

    Not yet reported University of Texas Southwestern Medical Center 140 participants Est. completion 2025-06-05 1 site Stand-alone
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Lipid Disorder
    View official trial listing →
  • Status unknown NCT NCT05565976

    Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

    Not yet reported, Not yet reported Jaime Daniel Mondragon 270 participants Est. completion 2025-07-01 1 site Stand-alone
    Cardiovascular diseaseMetabolic syndrome Other conditions: Mild Cognitive Impairment, Dementia, Vascular
    View official trial listing →
  • Status unknown NCT NCT05585151

    High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200 participants Est. completion 2024-10-01 1 site
    Other conditions: Cerebral Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT05613426

    Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI

    Not yet reported Henan Institute of Cardiovascular Epidemiology 119 participants Est. completion 2026-05-16 6 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05615012

    A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

    Not yet reported Bristol-Myers Squibb 76 participants Est. completion 2023-12-13 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05637060

    Bioequivalence Study of Rosuvastatin Tablet

    Not yet reported University of Karachi 36 participants Est. completion 2022-12-15 1 site
    Other conditions: Healthy Individuals
    View official trial listing →
  • Active, not recruiting NCT NCT05660135

    Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

    Daewoong Pharmaceutical Co. LTD. 4000 participants Est. completion 2025-12-31 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT05708573

    Potential Drug Interaction Between ALXN2040 and Rosuvastatin

    Not yet reported Alexion Pharmaceuticals, Inc. 20 participants Est. completion 2023-04-05 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT05731596

    Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

    Not yet reported Tanta University 46 participants Est. completion 2024-04
    MASH
    View official trial listing →
  • Completed NCT NCT05738291

    A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood

    Not yet reported Boehringer Ingelheim 67 participants Est. completion 2024-06-14 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05763459

    A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects

    Not yet reported Calico Life Sciences LLC 12 participants Est. completion 2023-06-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT05788328

    A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

    Not yet reported Pfizer 16 participants Est. completion 2023-09-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05789342

    A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers

    Not yet reported Jiangxi Qingfeng Pharmaceutical Co. Ltd. 54 participants Est. completion 2023-10-31 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT05828303

    A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

    Not yet reported Turning Point Therapeutics, Inc. Est. completion 2025-11-30 33 sites Stand-alone
    Other conditions: Advanced Solid Tumor, Metastatic Solid Tumor
    View official trial listing →
  • Active, not recruiting NCT NCT05889143

    A Study to Evaluate the Efficacy and Safety of CREZET Tablet

    Daewoong Pharmaceutical Co. LTD. 15000 participants Est. completion 2026-03-01 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT05893849

    Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults

    Peking University Third Hospital 624 participants Est. completion 2024-04 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT05895123

    Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

    Not yet reported Damanhour University 80 participants Est. completion 2023-04-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05926180

    Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)

    Not yet reported Dizal Pharmaceuticals 25 participants Est. completion 2024-09-28 1 site Stand-alone
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT05984953

    Rosuvastatin and Evolocumab for Coronary Artery Disease

    Icahn School of Medicine at Mount Sinai 195 participants Est. completion 2022-10-28 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06031454

    Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 56 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT06036784

    Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

    Not yet reported MBX Biosciences 69 participants Est. completion 2024-12-05 1 site Stand-alone
    Other conditions: Postbariatric Hypoglycemia
    View official trial listing →
  • Completed NCT NCT06048588

    YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

    Not yet reported, Not yet reported Beijing Inno Medicine Co., Ltd. 144 participants Est. completion 2025-04-27 6 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06081166

    A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

    Not yet reported NewAmsterdam Pharma 74 participants Est. completion 2024-01-22 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06092931

    A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

    Not yet reported DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 28 participants Est. completion 2023-11-28 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06105060

    Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis

    Not yet reported Beni-Suef University 175 participants Est. completion 2024-06-27 1 site
    Other conditions: Non-alcoholic Steatohepatitis
    View official trial listing →
  • Status unknown NCT NCT06134635

    Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

    Xuanwu Hospital, Beijing 80 participants Est. completion 2024-12-01
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT06153433

    Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

    Not yet reported Yonsei University 112 participants Est. completion 2024-08 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT06160414

    A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants

    Not yet reported Alexion Pharmaceuticals, Inc. 20 participants Est. completion 2024-02-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06186622

    A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

    Not yet reported Eli Lilly and Company 50 participants Est. completion 2024-07-10 2 sites Stand-alone
    Other conditions: Healthy, Obese, Overweight
    View official trial listing →
  • Completed NCT NCT06191991

    A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

    Not yet reported Aligos Therapeutics 14 participants Est. completion 2023-12-04 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06225635

    A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

    Not yet reported Shin Poong Pharmaceutical Co. Ltd. 60 participants Est. completion 2022-03-07 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT06262685

    Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins

    Not yet reported Instituto de Investigación Hospital Universitario La Paz 216 participants Est. completion 2025-03-04 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy
    View official trial listing →
  • Status unknown NCT NCT06273215

    Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients

    Not yet reported Peking University Third Hospital 48 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT06279234

    A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

    Not yet reported Pfizer 50 participants Est. completion 2025-04-11 2 sites Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06293261

    Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

    Yuhan Corporation 5047 participants Est. completion 2024-03-31 39 sites
    Other conditions: Hypertension, Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT06304896

    Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy

    Not yet reported Arab Contractors Medical Centre 150 participants Est. completion 2025-12-01 1 site
    Other conditions: Chemotherapy Induced Systolic Dysfunction
    View official trial listing →
  • Active, not recruiting NCT NCT06317051

    Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

    Not yet reported Kirby Institute 300 participants Est. completion 2027-12 10 sites
    Other conditions: HIV Infections, Weight Gain
    View official trial listing →
  • Completed NCT NCT06329895

    A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants

    Not yet reported Bayer 15 participants Est. completion 2024-06-10 1 site Stand-alone
    Other conditions: Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06335134

    A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 57 participants Est. completion 2024-06-28 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT06348290

    Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

    Not yet reported Jemincare 72 participants Est. completion 2024-09-15 Stand-alone
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Completed NCT NCT06416800

    A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants

    Not yet reported Incyte Corporation 71 participants Est. completion 2025-01-15 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06491550

    A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants

    Not yet reported AstraZeneca 91 participants Est. completion 2025-06-11 2 sites Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06503679

    A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants

    Not yet reported DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 49 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06515652

    To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome

    Not yet reported Hamdard University 200 participants Est. completion 2024-08-30 1 site
    Metabolic syndrome
    View official trial listing →
  • Withdrawn NCT NCT06533280

    VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

    Not yet reported ViiV Healthcare Est. completion 2024-08-14 1 site Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT06554821

    A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

    Not yet reported AstraZeneca 28 participants Est. completion 2024-10-08 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06567327

    A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

    Not yet reported Pfizer 82 participants Est. completion 2025-04-14 3 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06578676

    To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults

    Not yet reported Hyundai Pharm 56 participants Est. completion 2024-11-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT06594159

    A Study of LY4065967 in Healthy Japanese Participants

    Not yet reported Eli Lilly and Company 59 participants Est. completion 2025-03-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Enrolling by invitation NCT NCT06646354

    To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia

    Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Hypertension, Primary Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT06696820

    Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

    Not yet reported, Not yet reported Xiang Luo 429 participants Est. completion 2026-06-03 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06717269

    A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

    Not yet reported Nurix Therapeutics, Inc. 223 participants Est. completion 2026-05-01 2 sites Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT06782243

    Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome

    Not yet reported Khyber Medical University Peshawar 190 participants Est. completion 2025-08-25 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06785727

    StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial

    Not yet reported Prof. dr. Nathalie van der Velde 612 participants Est. completion 2029-07-01 Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Not yet recruiting NCT NCT06791031

    PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)

    Not yet reported West China Hospital 212 participants Est. completion 2028-06 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06813924

    A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

    Not yet reported Novo Nordisk A/S 37 participants Est. completion 2025-05-27 1 site Stand-alone
    Other conditions: Healthy Volunteers Sickle Cell Disease, Thalassemia
    View official trial listing →
  • Active, not recruiting NCT NCT06820086

    Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention

    Not yet reported Mikk JÜRISSON 2714 participants Est. completion 2034-03 2 sites Stand-alone
    Other conditions: PRS-based Primary Prevention of CVD
    View official trial listing →
  • Completed NCT NCT06821698

    To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers

    Not yet reported Kaken Pharmaceutical 38 participants Est. completion 2025-05-20 1 site Stand-alone
    Other conditions: Healty Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT06834932

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

    Not yet reported, Not yet reported AstraZeneca 432 participants Est. completion 2027-02-22 42 sites Stand-alone
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Not yet recruiting NCT NCT06856772

    Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial

    Not yet reported Tor Biering-Sørensen 42000 participants Est. completion 2028-03-28 1 site Stand-alone
    Cardiovascular disease Other conditions: Drug Effect
    View official trial listing →
  • Active, not recruiting NCT NCT06899061

    Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

    Not yet reported AstraZeneca 41 participants Est. completion 2028-05-19 4 sites
    Other conditions: Advanced Solid Malignancies
    View official trial listing →
  • Completed NCT NCT06921941

    Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

    Not yet reported Atea Pharmaceuticals, Inc. 38 participants Est. completion 2025-07-02 1 site Stand-alone
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Completed NCT NCT06948747

    A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

    Not yet reported AstraZeneca 49 participants Est. completion 2025-10-03 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06949124

    A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2025-06-05 1 site
    Other conditions: Endometriosis, Uterine Fibroids, Assisted Reproduction
    View official trial listing →
  • Completed NCT NCT06975605

    Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

    Not yet reported GRIN Therapeutics, Inc. 18 participants Est. completion 2025-07-10 1 site Stand-alone
    Other conditions: Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT06982131

    A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

    Not yet reported Hoffmann-La Roche 40 participants Est. completion 2026-12-07 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT07065058

    A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects

    Not yet reported Vincentage Pharma Co., Ltd 24 participants Est. completion 2025-08-11 1 site Stand-alone
    Other conditions: Obesity &Amp; Overweight
    View official trial listing →
  • Completed NCT NCT07074834

    Metoprolol and Trimetazidine for Coronary Heart Disease With Angina

    Not yet reported Shiyan City Renmin Hospital 102 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Coronary Heart Disease (CHD)
    View official trial listing →
  • Completed NCT NCT07097831

    A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2025-11-07 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT07158398

    Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate

    Not yet reported Deciphera Pharmaceuticals, LLC 20 participants Est. completion 2025-12-08 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07182383

    Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2025-11-24 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT07201545

    Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2025-12-10 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT07216482

    A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

    Not yet reported Merck Sharp & Dohme LLC 996 participants Est. completion 2026-11-05 87 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Active, not recruiting NCT NCT07218900

    A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

    Not yet reported AstraZeneca 76 participants Est. completion 2026-09-30 8 sites Stand-alone
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT07223671

    Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

    Not yet reported Bristol-Myers Squibb 30 participants Est. completion 2026-03-19 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT07235748

    Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

    Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2025-12-23 1 site Stand-alone
    Other conditions: Healthy Adult Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07239414

    Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability

    Not yet reported Sohaib Ashraf 690 participants Est. completion 2027-02-21
    Other conditions: Cardiovascular
    View official trial listing →
  • Completed NCT NCT07255820

    Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

    Not yet reported Bahria University 126 participants Est. completion 2026-06-30 1 site
    Type 2 diabetes Other conditions: Hypercholesterolemia / Elevated LDL Cholesterol
    View official trial listing →
  • Not yet recruiting NCT NCT07290699

    Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

    Not yet reported Second Affiliated Hospital of Nanchang University 2442 participants Est. completion 2028-08-30 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07313124

    Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases

    Not yet reported, Not yet reported Beni-Suef University 66 participants Est. completion 2025-12-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07316608

    A Phase I Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults

    Not yet reported AstraZeneca 44 participants Est. completion 2026-06-05 2 sites Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07349394

    Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 18 participants Est. completion 2026-03-12 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Not yet recruiting NCT NCT07378293

    Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

    Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 2 sites Stand-alone
    Other conditions: Diabete Mellitus, Lipid Profile
    View official trial listing →
  • Completed NCT NCT07431866

    A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

    Not yet reported Merck Sharp & Dohme LLC 41 participants Est. completion 2026-06-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07432516

    Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial

    Not yet reported Yonsei University 4400 participants Est. completion 2033-06 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07474649

    A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

    Not yet reported Daiichi Sankyo 103 participants Est. completion 2028-10-02 12 sites Stand-alone
    Other conditions: Coronary Atherosclerosis, Mixed Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07504198

    Neuroprotection of Memantine and Rosuvastatin

    Not yet reported, Not yet reported Tanta University 46 participants Est. completion 2027-05 1 site
    Other conditions: Peripheral Nerve Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Not yet recruiting NCT NCT07605130

    Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial

    Not yet reported Peking Union Medical College Hospital 440 participants Est. completion 2029-07-31 1 site Stand-alone
    Other conditions: Intracranial Arteriosclerosis, Cognitive Impairment
    View official trial listing →
  • Not yet recruiting NCT NCT07619118

    A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

    Not yet reported AstraZeneca 200 participants Est. completion 2027-05-28 Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Not yet recruiting NCT NCT07626840

    Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

    Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31
    Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
    View official trial listing →
  • Not yet recruiting NCT NCT07674524

    Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

    Sun Yat-sen University 160 participants Est. completion 2029-12-31 1 site
    Other conditions: Non-Small Cell Lung Cancer (NSCLC), Hyperlipidemia, ALK Gene Mutation, ALK-positive
    View official trial listing →
  • Completed NCT NCT07692685

    Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants

    Not yet reported Neurodawn Pharmaceutical Co., Ltd. 20 participants Est. completion 2026-06-04 1 site
    Other conditions: Drug Drug Interaction, Pharmacokinetic Profiles, Safty
    View official trial listing →
  • Not yet recruiting NCT NCT07699003

    Endovascular Treatment of Chronic Intracranial Artery Occlusion

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 382 participants Est. completion 2030-08-01
    Other conditions: Chronic Intracranial Artery Occlusion
    View official trial listing →
  • Completed NCT NCT07717788

    Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

    Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Osteoporosis, Postmenopausal, Statin Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07785830

    A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)

    Not yet reported Merck Sharp & Dohme LLC 16 participants Est. completion 2026-11-10 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07820891

    A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395

    Not yet reported BeOne Medicines 24 participants Est. completion 2026-11-22 Stand-alone
    Other conditions: Healthy Adult Participants
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Rosuvastatin Calcium, Rosuvastatin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.